Effect of High Protein ONS on Older Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 23, 2024

Conditions
Locally Advanced Gastric Adenocarcinoma
Interventions
DIETARY_SUPPLEMENT

oral nutritional supplement

The ONS group received a high-protein ONS providing 18.8 g of protein, 7 g of fat, 28 g of carbohydrates, and 250 calories of energy per 200 mL and medical nutrition therapy. The product is gluten-free and contains lactose, minerals, trace elements, and vitamins . The Control group received only standard nutrition therapy without ONS supplementation.

Trial Locations (1)

24000

Erzincan Binali Yıldırım Üniversitesi Mengücek Gazi Eğitim ve Araştırma. Hastanesi, Erzincan

All Listed Sponsors
lead

Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital

OTHER_GOV